Dr. Shirin Attarian, MD

Dr. Attarian practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Attarian's NPI, 1427310713, was assigned on June 12, 2012. Dr. Attarian graduated from Shahid Beheshti University of Medical Sciences in 2009. Dr. Attarian's California license number on file is C190504.

Dr. Attarian's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Attarian's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Attarian practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Attarian's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Attarian is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Attarian's licenses on file in 2 states: California and New York.

Dmand AI lists breast cancer, lung cancer and prostate cancer among the conditions Dr. Attarian treats.

CMS data shows 194 Medicare services from Dr. Attarian across 4 procedure codes in 2024, for 84 Medicare patients. Medicare paid $23,920 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 84 Medicare patients who saw Dr. Attarian in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Attarian's median patient age at 69, with 31% women.

In 2024, Dr. Attarian wrote 181 Medicare Part D claims for 28 patients. 95% of them were for generic drugs. CMS names the drug for 109 of them, across 4 drugs with 11 or more claims each, at $1,136 in total drug cost. In 2023, CMS named 24 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Attarian for performance year 2024, reported through an alternative payment model (APM). Dr. Attarian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Attarian as offering telehealth.

Dmand AI links 17 papers to Dr. Attarian, published from 2009 to 2023. 2016 was the busiest year, with 3. The most frequent topics are Bone Marrow, Muscle, Skeletal and Biopsy, Needle. Dr. Attarian has published most often in Rev Neurol (Paris). Dr. Attarian's most frequent co-authors are Tarek Elrafei, DO, Missak Haigentz, MD and Balazs Halmos, MD.

CMS Open Payments shows 7 general payments to Dr. Attarian from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 82% of the total. Sanofi and Genzyme US Companies paid the most, $2,538.

Dr. Attarian graduated from Shahid Beheshti University of Medical Sciences in 2009.

Dr. Attarian is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.